Retrospective analysis of long-term survival factors in patients with advanced non-small cell lung cancer treated with nivolumab.

Yusuke MurakamiAkihiro TamiyaYoshihiko TaniguchiYuichi AdachiTakatoshi EnomotoKoji AzumaYuji InagakiShunichi KounoYoshinobu MatsudaKyoichi OkishioShinji Atagi

Published in: Thoracic cancer (2022)

ΔNLR <1 was a significant long-term survival factor compared to ΔNLR ≥1 in advanced NSCLC patients treated with nivolumab.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
small cell lung cancer
newly diagnosed